Home/Filings/4/0000899243-15-005031
4//SEC Filing

Aegerion Pharmaceuticals, Inc. 4

Accession 0000899243-15-005031

CIK 0001338042operating

Filed

Sep 17, 8:00 PM ET

Accepted

Sep 18, 4:08 PM ET

Size

5.7 KB

Accession

0000899243-15-005031

Insider Transaction Report

Form 4
Period: 2015-09-17
Transactions
  • Award

    Stock Option (right to buy)

    2015-09-17+31,18231,182 total
    Exercise: $17.68Exp: 2025-09-17Common Stock (31,182 underlying)
Footnotes (2)
  • [F1]The stock option award has an exercise price equal to the closing price of the Issuer's common stock on the Nasdaq Global Select Market on the date of grant.
  • [F2]The 31,182 shares of common stock underlying this option will vest in equal one-third increments on September 17, 2016, September 17, 2017 and September 17, 2018.

Issuer

Aegerion Pharmaceuticals, Inc.

CIK 0001338042

Entity typeoperating
IncorporatedDE

Related Parties

1
  • filerCIK 0001338042

Filing Metadata

Form type
4
Filed
Sep 17, 8:00 PM ET
Accepted
Sep 18, 4:08 PM ET
Size
5.7 KB